BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34174265)

  • 21. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
    Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
    Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
    Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
    Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis.
    Li W; Tai Y; Zhou J; Gu W; Bai Z; Zhou T; Zhong Z; McCue PA; Sang N; Ji JY; Kong B; Jiang J; Wang C
    Cell Cycle; 2012 Jun; 11(12):2348-58. PubMed ID: 22672904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.
    Yin F; Feng F; Wang L; Wang X; Li Z; Cao Y
    Cell Death Dis; 2019 Sep; 10(9):672. PubMed ID: 31511501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zhiheshouwu ethanol extract induces intrinsic apoptosis and reduces unsaturated fatty acids via SREBP1 pathway in hepatocellular carcinoma cells.
    Li H; Xiang L; Yang N; Cao F; Li C; Chen P; Ruan X; Feng Y; Zhou N; Wang X
    Food Chem Toxicol; 2018 Sep; 119():169-175. PubMed ID: 29702135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.
    Xiang Q; Zhen Z; Deng DY; Wang J; Chen Y; Li J; Zhang Y; Wang F; Chen N; Chen H; Chen Y
    J Exp Clin Cancer Res; 2015 Oct; 34():118. PubMed ID: 26458953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis.
    Zhao Z; Zhong L; He K; Qiu C; Li Z; Zhao L; Gong J
    Biochem Biophys Res Commun; 2019 Feb; 509(4):855-861. PubMed ID: 30638930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H; Ge C; Sun H; Li H; Li J; Tian H
    Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
    Hu M; Wang M; Lu H; Wang X; Fang X; Wang J; Ma C; Chen X; Xia H
    Oncotarget; 2016 Jul; 7(28):43419-43431. PubMed ID: 27270326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
    Xu D; Wang Z; Xia Y; Shao F; Xia W; Wei Y; Li X; Qian X; Lee JH; Du L; Zheng Y; Lv G; Leu JS; Wang H; Xing D; Liang T; Hung MC; Lu Z
    Nature; 2020 Apr; 580(7804):530-535. PubMed ID: 32322062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
    Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
    Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
    Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
    Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
    Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
    J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.
    Poolsri WA; Phokrai P; Suwankulanan S; Phakdeeto N; Phunsomboon P; Pekthong D; Richert L; Pongcharoen S; Srisawang P
    Biomed Res Int; 2018; 2018():3683026. PubMed ID: 29546056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
    Dai H; Li M; Yang W; Sun X; Wang P; Wang X; Su J; Wang X; Hu X; Zhao M
    Aging (Albany NY); 2020 Jun; 12(12):11717-11731. PubMed ID: 32530437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.